MOOD — Doseology Sciences Balance Sheet
0.000.00%
Last trade - 00:00- CA$4.43m
- CA$3.50m
- CA$0.10m
- 53
- 10
- 60
- 35
Annual balance sheet for Doseology Sciences, fiscal year end - June 30th, CAD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 0.341 | 3.73 | 1.87 | 1.3 | 1.06 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.81 | 0.044 | 0.085 | 0.017 | 0.002 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 1.16 | 5 | 2.97 | 1.34 | 1.1 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | — | 0.907 | 0.883 | 0.056 | 0 |
| Net Intangible Assets | |||||
| Total Assets | 1.16 | 5.99 | 3.87 | 1.4 | 1.1 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.088 | 3.41 | 0.219 | 0.092 | 0.082 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 0.088 | 3.41 | 0.872 | 0.099 | 0.082 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 1.07 | 2.58 | 3 | 1.3 | 1.02 |
| Total Liabilities & Shareholders' Equity | 1.16 | 5.99 | 3.87 | 1.4 | 1.1 |
| Total Common Shares Outstanding |